The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal adult‐onset disease primarily characterized by upper and lower motor neuron degeneration, muscle wasting and paralysis. It is increasingly accepted that the pathological process leading to ALS is the result of multiple disease mechanisms that operate wi...
Saved in:
Published in | Brain pathology (Zurich, Switzerland) Vol. 26; no. 2; pp. 227 - 236 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Blackwell Publishing Ltd
01.03.2016
John Wiley & Sons, Inc John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Amyotrophic lateral sclerosis (ALS) is a fatal adult‐onset disease primarily characterized by upper and lower motor neuron degeneration, muscle wasting and paralysis. It is increasingly accepted that the pathological process leading to ALS is the result of multiple disease mechanisms that operate within motor neurons and other cell types both inside and outside the central nervous system. The implication of skeletal muscle has been the subject of a number of studies conducted on patients and related animal models. In this review, we describe the features of ALS muscle pathology and discuss on the contribution of muscle to the pathological process. We also give an overview of the therapeutic strategies proposed to alleviate muscle pathology or to deliver curative agents to motor neurons. ALS muscle mainly suffers from oxidative stress, mitochondrial dysfunction and bioenergetic disturbances. However, the way by which the disease affects different types of myofibers depends on their contractile and metabolic features. Although the implication of muscle in nourishing the degenerative process is still debated, there is compelling evidence suggesting that it may play a critical role. Detailed understanding of the muscle pathology in ALS could, therefore, lead to the identification of new therapeutic targets. |
---|---|
Bibliography: | istex:1C90A6ABE0A86030126FE6C04D909B9EB38584CC ArticleID:BPA12350 Association Française contre les Myopathies (AFM) American Amyotrophic Lateral Sclerosis Association (ALSA) Thierry Latran Foundation European Community's Health Seventh Framework - No. 259867 (Euro-MOTOR) ark:/67375/WNG-8CFDWQF8-W Association de Recherche sur la Sclérose Latérale Amyotrophique (ARsla) These authors contributed equally to this work. The authors declare that there is no conflict of interest. Conflict of interest ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Conflict of interest: The authors declare that there is no conflict of interest. |
ISSN: | 1015-6305 1750-3639 1750-3639 |
DOI: | 10.1111/bpa.12350 |